Literature DB >> 54582

A simplified assessment of response to parathyroid hormone in hypoparathyroid patients.

S Tomlinson, G N Hendy, J H O'Riordan.   

Abstract

Hightly purified bovine parathyroid hormone (B.P.T.H) was given by injection and/or infusion to six normal volunteers and to patients with surgical hypoparathyroidism (five cases), idiopathic hyparathyroidism (five cases), or poeudo-hypoparathyroidism (six cases). Infusion and injection of B.P.T.H. produced very similar patterns of response in plasma adenosine 3' 5' cyclic monophosphate (cyclic A.M.P.) In all six normal volunteers and in the patients with surgical (five cases) or idiopathic (four cases) hypoparathyroidism who had injections of B.P.T.H., plasma-cA.M.P. had risen significantly within 5 min and the peak response was genereally observed 10 min after injection of hormone. In the five pseudohypoparathyroid patients who received injections of B.P.T.H., plasma-c?A.M.P. concentration increased only slightly or not at all after the hormone was administered. Unlike the traditional test for the investigation of hypocalcaemia, the test described here does not require collections of urine samples.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 54582     DOI: 10.1016/s0140-6736(76)90152-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  RDCI, the vasoactive intestinal peptide receptor: a candidate gene for the features of Albright hereditary osteodystrophy associated with deletion of 2q37.

Authors:  M M Power; R S James; J C Barber; A M Fisher; P J Wood; B A Leatherdale; D E Flanagan; E Hatchwell
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

2.  A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone.

Authors:  K Kruse; U Kracht
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

3.  Plasma adenosine 3',5'-cyclic monophosphate: dose-response to injected bovine parathyroid hormone in man.

Authors:  I G Lewin; G N Hendy; S E Papapoulos; S Tomlinson; J L O'Riordan
Journal:  Calcif Tissue Res       Date:  1977-05

4.  Postnatal establishment of allelic Gαs silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous Gαs disruption.

Authors:  Serap Turan; Eduardo Fernandez-Rebollo; Cumhur Aydin; Teuta Zoto; Monica Reyes; George Bounoutas; Min Chen; Lee S Weinstein; Reinhold G Erben; Vladimir Marshansky; Murat Bastepe
Journal:  J Bone Miner Res       Date:  2014-03       Impact factor: 6.741

5.  Prevalences of CT-detected calcification in the basal ganglia in idiopathic hypoparathyroidism and pseudohypoparathyroidism.

Authors:  F Illum; E Dupont
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

Review 6.  Albright's hereditary osteodystrophy.

Authors:  L C Wilson; R C Trembath
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

7.  Differential diagnosis of hypoparathyroid disorders during childhood.

Authors:  M Ishida; Y Seino; T Simotsuji; T Ishii; K Yamaoka; T Harada; H yabuuchi; K Nishimura
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

8.  Transient neonatal hyperparathyroidism secondary to maternal pseudohypoparathyroidism.

Authors:  E J Glass; D G Barr
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

9.  Pseudohypoparathyroidism presenting as severe Parkinsonism.

Authors:  D W Pearson; W F Durward; I Fogelman; I T Boyle; G Beastall
Journal:  Postgrad Med J       Date:  1981-07       Impact factor: 2.401

10.  Hypercalciuria in idiopathic Fanconi syndrome.

Authors:  K Kruse; H Bartels
Journal:  Eur J Pediatr       Date:  1979-08       Impact factor: 3.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.